问题: 请哪位高手帮我翻译以下一段文字,非常感谢
首先,感觉贵司给予到我面试的机会。
我叫**,来自湖南怀化,2005年6月毕业于湖南中医药大学中医学专业本科,期间约1年的时间在中南大学湘雅附三医院实习,毕业后回到了家乡与父母开诊所。处于性格方面及职业的向往,于2006年8月又回到了长沙并顺利入职北京甘李药业,主要负责胰岛素的推广,从当时的接手时销量为零到半月内消化完所有库存。2007年2月开始兼开发工作,5月底顺利开发了浏阳市人民医院,其他的比如湘雅附三医院、长沙市第七医院、望城县人民医院等临床主任已同意新药引进,只等到药事委员会开启。
2007年8月入职上海强生制药,主要负责长沙市湘雅附二医院、湘雅附三医院等13家医院及衡阳市南华附一医院、南华附二医院等5家医院,共13家医院的维护推广工作。当时接手时销量为3、4万(考核价),在12月底实现翻番,也就是8万多。因……故提出辞职申请,目前处于离职状态。
谢谢。
解答:
First of all, I feel your company to give interviews opportunities.
My name is--- . I come from Huaihua, Hunan, in June 2005 graduated from Hunan Medical University undergraduate in the medical profession, during about one year's time in the Central South University of the Third Xiangya Hospital internship after graduation I returned to the home with my parents' opened clinics . In character and in yearning for a career in August 2006 has returned to the smooth entry of Changsha and Beijing Gan Li medicine, is mainly responsible for the promotion of insulin, then took over from zero to a half months when sales digested all the inventory. In February 2007 and began development work by the end of May to develop a Liuyang City People's Hospital, the other three of Xiangya Hospital, for example, the seventh hospital in Changsha City, Wangcheng County People's Hospital clinical director has agreed to the introduction of new drugs, only until Pharmaceutical Committee opened.
August 2007 recruits Shanghai Qiangsheng pharmaceuticals, primarily responsible for two of Changsha Xiangya Hospital, Xiangya Hospital of the three hospitals and 13 of the South China Hengyang City Hospital, the South China of two hospitals, five hospitals, a total of 13 The hospital's maintenance promotion. At that time, took over the sales of 3,4 million (appraisal price), at the end of December to double, which is more than 80,000. …… Is due to the application submitted his resignation and is currently in a state of separation.
版权及免责声明
1、欢迎转载本网原创文章,转载敬请注明出处:侨谊留学(www.goesnet.org);
2、本网转载媒体稿件旨在传播更多有益信息,并不代表同意该观点,本网不承担稿件侵权行为的连带责任;
3、在本网博客/论坛发表言论者,文责自负。